期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CHEMISTRY OF NATURAL COMPOUNDS LetPub Score 5.1
50 ratings
Rate
Reputation 6.1 Influence 3.7 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | CHEM NAT COMPD+ | ||||||||||||||||||||||||
ISSN | 0009-3130 | ||||||||||||||||||||||||
E-ISSN | 1573-8388 | ||||||||||||||||||||||||
h-index | 34 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 37.50%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.springer.com/10600 | ||||||||||||||||||||||||
在線稿件提交 | |||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Springer US | ||||||||||||||||||||||||
主題領域 | 化学 | ||||||||||||||||||||||||
出版國/地區 | UZBEKISTAN | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 1965 | ||||||||||||||||||||||||
每年文章數 | 308每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 0.00% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0009-3130%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 9.0 month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 66.66% | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CHEMISTRY OF NATURAL COMPOUNDS] 的評論 | 撰寫評論 |
作者: 啦啦德玛西亚 領域: 医学 審稿時間: 12.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-20 09:38:44 評論於 Are you submitting a review or a research article?(0) 讚! | 啦啦德玛西亚 |
作者: zyfan 領域: 医学 審稿時間: 12.0 month(s) 結果: 直接被接受 撰寫評論 |
2020-04-21 14:22:57 評論於 Very slow, really slow... The paper was submitted in December 2018. When it was in November 2019, the manuscript was scheduled for publication on the second issue of 2020. I don't know it was for the epidemic or any other reason. Unbelievable! (0) 讚! | zyfan |
作者: 匿名 領域: 審稿時間: 0.0 month(s) 結果: 修改後接受 撰寫評論 |
2013-07-09 09:18:00 評論於 I submitted in July last year, and my article was returned with a request for revision in September. There has been no news since. At the beginning of July this year, I suddenly received an email asking me to transfer the copyright. Because there are so many brief communications in each issue, the impact factor is unlikely to get higher. (0) 讚! | 匿名 |
作者: 匿名 領域: 審稿時間: 12.0 month(s) 結果: 直接被接受 撰寫評論 |
2012-04-25 15:56:00 評論於 After submitting the manuscript, contact with the editor. The reception will be published soon. You need to wait for(0) 讚! | 匿名 |
作者: 匿名 領域: 化学科学 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2012-03-26 12:41:00 評論於 . If you select, don’t worry, you will be notified after 12-18 months, submit the copyright.The transfer agreement can be read in 2-3 months.Usually 18-24 months, it is easier.Articles in Chinese journals such as Chinese Journal of Traditional Chinese Medicine, Chinese Herbal Medicine, and Chinese Pharmacy Magazine can be included.It is a long time.(0) 讚! | 匿名 |
作者: 匿名 領域: 審稿時間: 6.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-02-17 15:26:00 評論於 No news for 6 months, wrote a reminder letter, edited the letter to make the manuscript, and revised the manuscript for the past two months. Waiting for the news, in general,Journals are slow, be patient and wait(0) 讚! | 匿名 |
作者: 匿名 領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2011-08-18 20:29:00 評論於 Journal Homepage URL: http://www.springer.com/biomed/p ... ience/journal/10600(0) 讚! | 匿名 |
作者: 匿名 領域: 医药科学 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2011-07-19 19:30:00 評論於 The impact factor is around 0.5, which is relatively easy, and it is also easier to be ignored by one of the SCI journals, suitable for a new compound, or for some separation for the first time.A compound, or several known compounds that are active.Papers on essential oils are also widely included (first reported).(0) 讚! | 匿名 |
作者: 匿名 領域: 医药科学 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2011-05-07 17:39:00 評論於 This journal requires general, as long as it is a new substance, 100% can be recommended, you can try it if you need it urgently, after all, it is still SCI.(0) 讚! | 匿名 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us